Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Completed · Phase 3

Conditions studied: Dry Eye Syndromes

In brief

This study will evaluate the safety, efficacy, and acceptability of an eye drop formulation in subjects with dry eye disease.

Key facts

Study ID

NCT01459588

Run by

Allergan

People needed

315

Starts

2011-10-01

Expected to finish

2012-02-15

Last updated by the study team

2019-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dry eyes
• Current use of eye drops for dry eye at least twice daily, on average for at least 3 months

You may not qualify if…

• Cataract, laser-assisted in situ keratomileusis (LASIK), or photorefractive keratectomy (PRK) surgery in the last 12 months
• Need to wear contact lenses during the study, or has worn contact lenses in the last 6 months
• Active ocular allergy

Where it is running

• Study site — Petaluma, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.